+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Epidemiology of coronary heart disease in patients with human immunodeficiency virus



Epidemiology of coronary heart disease in patients with human immunodeficiency virus



Reviews in Cardiovascular Medicine 15(Suppl. 1): S1-S8



As a growing number of patients infected with human immunodeficiency virus (HIV) have access to antiretroviral therapy and achieve virologic suppression, the focus of clinical care is shifting from treating the infectious complications of advanced immunodeficiency to managing and preventing chronic disease. The aging of the HIV-positive population and increased rates of chronic disease complications in the setting of HIV infection have increased the impact of noncommunicable diseases such as coronary heart disease (CHD). The effect of HIV on CHD is independent of traditional cardiovascular risk factors and antiretroviral medications and is likely due in part to the chronic inflammation and immune activation underlying HIV infection. This article describes the current state of epidemiologic knowledge on CHD in HIV infection. It highlights key studies in the field and summarizes epidemiologic data with respect to traditional and novel CHD risk factors, specialized clinical subgroups, and broader cardiovascular outcomes.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 053009132

Download citation: RISBibTeXText

PMID: 24987859


Related references

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation 119(6): 805-811, 2009

Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clinical Infectious Diseases 37(2): 292-298, 2003

Epidemiology and pathogenesis of human immunodeficiency virus (HIV) related heart disease: a review. Nigerian Journal of Medicine 14(3): 255-260, 2005

Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Archives of Internal Medicine 171(8): 737-743, 2011

Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil. Metabolic Syndrome and Related Disorders 8(6): 489-497, 2010

Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities. International Journal of Cardiology 218: 43-46, 2016

Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation 129(17): 1781-1789, 2014

Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and review. Clinical Cardiology 24(10): 690-694, 2001

Risk factors prevalence for coronary heart disease in human immunodeficiency virus infected individuals. Zhonghua Xin Xue Guan Bing Za Zhi 42(11): 974-976, 2014

Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults. Metabolic Syndrome and Related Disorders 8(3): 279-286, 2010

Epidemiology, pathogenesis, and management of human immunodeficiency virus infection in patients with periodontal disease. Periodontology 2000 44: 55-81, 2007

Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. Eurointervention 12(14): 1757-1765, 2017

Acute coronary syndrome in patients with human immunodeficiency virus disease. Angiology 53(5): 545-549, 2002

Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients. World Journal of Nephrology 4(3): 388-395, 2015

Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. European Heart Journal 33(7): 866-874, 2012